Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 126 entries
View as:

Deep Brain Stimulation of NAc/ALIC to Prevent Treatment-Refractory Obsessive Compulsive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02601677 Org: User:
Start: 11/30/15 End: 11/30/18 Due: 11/30/19

Study on the Molecular Mechanism of Diarrhea-predominant Irritable Bowel Syndrome With Anxiety and Depression Based on Multi-omics Correlation Analysis

Phase: N/A Priority: Normal
NCT ID: NCT05311293 Org: User:
Start: 11/01/21 End: 12/31/23 Due: 12/31/24

Open-Label Extension of Tocilizumab in Subjects With Generalized Myasthenia Gravis

Phase: N/A Priority: Normal
NCT ID: NCT05716035 Org: User:
Start: 04/01/23 End: 12/31/24 Due: 12/31/25

Multiple B-value Diffusion-weighted Imaging(DWI) in Evaluation of Breast Lesions

Phase: N/A Priority: Normal
NCT ID: NCT02529384 Org: User:
Start: 01/31/15 End: 12/31/19 Due: 12/31/20

Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis

Phase: N/A Priority: Normal
NCT ID: NCT05067348 Org: User:
Start: 07/21/22 End: 03/30/26 Due: 03/30/27

This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Combined With Chemotherapy With or Without Anlotinib in Resectable Limited-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06978153 Org: User:
Start: 05/20/25 End: 11/01/27 Due: 11/01/28

Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02518802 Org: User:
Start: 01/31/15 End: 01/31/20 Due: 01/31/21

Wound-healing Improvement by Resurfacing Split-Thickness Skin Donor Sites With Thin Split-thickness Grafting

Phase: N/A Priority: Normal
NCT ID: NCT01974583 Org: User:
Start: 01/31/02 End: 03/31/13 Due: 03/31/14

A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases

Phase: N/A Priority: Normal
NCT ID: NCT03427541 Org: User:
Start: 12/31/17 End: 04/30/18 Due: 04/30/19

Fingolimod in Minimal Invasive Treatment of Intracerebral Hemorrhage

Phase: N/A Priority: Normal
NCT ID: NCT06087965 Org: User:
Start: 10/11/23 End: 12/30/25 Due: 12/30/26

The Impact of Shallow Reading in Social Media

Phase: N/A Priority: Normal
NCT ID: NCT05097807 Org: User:
Start: 10/31/22 End: 06/30/24 Due: 06/30/25

The Early Warning System for the Diabetic Encephalopathy

Phase: N/A Priority: Normal
NCT ID: NCT02420470 Org: User:
Start: 04/30/15 End: 12/31/26 Due: 12/31/27

Mechanical Stimulation Improve the Fertilization in ICSI Cycle

Phase: N/A Priority: Normal
NCT ID: NCT03810001 Org: User:
Start: 11/11/18 End: 12/25/19 Due: 12/25/20

Development and Validation of a Deep Learning-Based Survival Prediction Model for Pediatric Glioma Patients: A Retrospective Study Using the SEER Database and Chinese Data

Phase: N/A Priority: Normal
NCT ID: NCT06199388 Org: User:
Start: 09/20/22 End: 12/20/23 Due: 12/20/24

Investigation of Clinical Feature and Brain Function in Narcoleptic Patients

Phase: N/A Priority: Normal
NCT ID: NCT03376568 Org: User:
Start: 01/28/16 End: 12/30/19 Due: 12/30/20

The Influencing Factors and Prediction Model of Poor Prognosis of Spontaneous Intraparenchymal Hemorrhage

Phase: N/A Priority: Normal
NCT ID: NCT03899350 Org: User:
Start: 07/15/19 End: 12/31/25 Due: 12/31/26

A New Conception About Individualized Treatment Allocation for HCC

Phase: N/A Priority: Normal
NCT ID: NCT06008548 Org: User:
Start: 01/01/10 End: 10/01/21 Due: 10/01/22

Coagulopathy on the First Postoperative Day Predicts the Long-term Survival of Traumatic Brain Injury Patients

Phase: N/A Priority: Normal
NCT ID: NCT04322721 Org: User:
Start: 10/01/19 End: 01/31/20 Due: 01/31/21

Types of Intracellular Bacteria in Atherosclerotic Plaques and Analysis of Risk Factors

Phase: N/A Priority: Normal
NCT ID: NCT06935279 Org: User:
Start: 01/01/23 End: 01/01/27 Due: 01/01/28

Group Culture May Affect Embryo Quality in Assisted Reproduction Technology

Phase: N/A Priority: Normal
NCT ID: NCT04011319 Org: User:
Start: 04/01/19 End: 03/31/20 Due: 03/31/21

A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT06503042 Org: User:
Start: 08/01/24 End: 08/01/26 Due: 08/01/27

S-1 Combined Cisplatin HIPEC for Palliative Operation Gastric Cancer of Stage IV Limited Peritoneal Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT02291211 Org: User:
Start: 09/30/14 End: 12/31/16 Due: 12/31/17

A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03451526 Org: User:
Start: 12/01/17 End: 03/30/18 Due: 03/30/19

Diagnosis of Individuals With Pulmonary Nodules by Different Bronchoscopy Combination

Phase: N/A Priority: Normal
NCT ID: NCT02268162 Org: User:
Start: 04/30/15 End: 11/30/17 Due: 11/30/18

Neoadjuvant Adebrelimab + DOS in Locally Advanced Resectable Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06475417 Org: User:
Start: 05/24/24 End: 04/26/26 Due: 04/26/27